SZ 469 (Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base))
Pill with imprint SZ 469 is White, Elliptical / Oval and has been identified as Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base). It is supplied by Sandoz Inc..
Glimepiride/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/pioglitazone 4 mg / 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ 469
More about glimepiride/pioglitazone
- Glimepiride/pioglitazone Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: antidiabetic combinations
- FDA Alerts (2)
- Glimepiride and pioglitazone
- Pioglitazone and Glimepiride
- Pioglitazone and glimepiride (Advanced Reading)
Other brands: Duetact
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.